We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
KORU Medical Systems
KRMD
$184M
| $236K | ﹤0.01% |
+66,974
| New | +$290K |
|
2202
Williams Companies
WMB
$85.8B
| $235K | ﹤0.01% |
+9,934
| New | +$226K |
|
|
DS
2203
DELISTED
Drive Shack Inc.
DS
| $235K | ﹤0.01% |
+73,231
| New | +$199K |
|
|
AGCWW
2204
CALL
DELISTED
Altimeter Growth Corp Warrant
AGCWW
| $234K | ﹤0.01% |
19,993
| – | – |
|
2205
Ziff Davis
ZD
$1.95B
| $231K | ﹤0.01% |
+2,220
| New | +$209K |
|
2206
CALL
Johnson & Johnson
JNJ
$643B
| $230K | ﹤0.01% |
+1,400
| New | +$227K |
|
2207
Fastenal
FAST
$55.2B
| $229K | ﹤0.01% |
+9,122
| New | +$218K |
|
2208
Lifetime Brands
LCUT
$200M
| $229K | ﹤0.01% |
15,577
-4,265
| -21% | -$61.6K |
|
2209
Northeast Bank
NBN
$1.08B
| $229K | ﹤0.01% |
+8,693
| New | +$233K |
|
2210
Upwork
UPWK
$1.21B
| $227K | ﹤0.01% |
+5,074
| New | +$234K |
|
2211
CALL
CVS Health
CVS
$140B
| $226K | ﹤0.01% |
+3,000
| New | +$219K |
|
2212
Montauk Renewables
MNTK
$259M
| $226K | ﹤0.01% |
+20,541
| New | +$247K |
|
2213
SI-BONE Inc
SIBN
$795M
| $226K | ﹤0.01% |
7,119
-30,753
| -81% | -$946K |
|
|
AXDX
2214
DELISTED
Accelerate Diagnostics
AXDX
| $225K | ﹤0.01% |
2,713
-1,423
| -34% | -$144K |
|
2215
Lithia Motors
LAD
$8.17B
| $225K | ﹤0.01% |
577
-10,640
| -95% | -$3.82M |
|
2216
Lincoln Electric
LECO
$14.6B
| $224K | ﹤0.01% |
+1,825
| New | +$218K |
|
2217
Myomo
MYO
$36.9M
| $223K | ﹤0.01% |
+17,413
| New | +$211K |
|
2218
Badger Meter
BMI
$3.9B
| $222K | ﹤0.01% |
+2,386
| New | +$240K |
|
2219
L3Harris
LHX
$56.9B
| $221K | ﹤0.01% |
+1,090
| New | +$205K |
|
2220
Middlesex Water
MSEX
$1.08B
| $221K | ﹤0.01% |
+2,800
| New | +$212K |
|
|
CMLS
2221
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $220K | ﹤0.01% |
+24,133
| New | +$237K |
|
|
GSS
2222
DELISTED
Golden Star Resources Ltd.
GSS
| $220K | ﹤0.01% |
+74,489
| New | +$260K |
|
2223
AMN Healthcare
AMN
$1.35B
| $219K | ﹤0.01% |
+2,966
| New | +$220K |
|
2224
Hooker Furnishings Corp
HOFT
$150M
| $219K | ﹤0.01% |
6,014
-13,331
| -69% | -$456K |
|
|
NREF
2225
NexPoint Real Estate Finance
NREF
$323M
| $218K | ﹤0.01% |
+11,737
| New | +$210K |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.